Results 1 to 10 of about 52,371 (280)

C-reactive protein and ferritin levels and length of intensive care unit stay in patients with B-cell lymphomas treated with axicabtagene ciloleucel ☆

Hematology/Oncology and Stem Cell Therapy, 2021
Objective/Background: Chimeric antigen receptor (CAR) T-cell is an effective therapy in relapsed/refractory large B-cell lymphomas that, due to its unique toxicities, often requires escalation of care to the intensive care unit (ICU) setting.
Megan Melody, Zaid Abdel Rahman, Hollie Saunders, Paula Lengerke Diaz, Nicole Gannon, Allison Rosenthal, Ernesto Ayala, Han W. Tun, Hemant Murthy, Vivek Roy, James Foran, Januario E. Castro, Pramod Guru, Mohamed A. Kharfan-Dabaja   +13 more
doaj   +1 more source

Successful experience of treatment of a patient with generalized non-GCB- DLBCL using the R-mNHL-BFM-90 protocol with lenalidomide: case report and review of literature [PDF]

Терапевтический архив, 2018
Diffuse large B-cell lymphoma is categorized by gene expression profiling into germinal center (GCB) and activated B-cell (ABC) subtype, also referred to as non-germinal center B-cell (non-GCB) by immunohistochemistry. ABC DLBCL is characterized by NF-κB
N G GABEEVA, E E ZVONKOV, D A KOROLEVA, M M CHUKAVINA, T N OBUKHOVA, A M KOVRIGINA   +5 more
doaj   +1 more source

Ras interacting protein 1 facilitated proliferation and invasion of diffuse large B-cell lymphoma cells

Cancer Biology & Therapy, 2023
A GTPase binding protein, Ras interacting protein 1 (RASIP1), has been reported with a tumor-promoting role in lung cancer cells, and its role in lymphoma remains unknown. The analysis of medical databank shows that RASIP1 is upregulated in diffuse large
Xiaojing Xing, Xuguang Wang, Meichen Liu, Qianxue Guo, Hongyue Wang   +4 more
doaj   +1 more source

Genome wide exploration of the methylome in aggressive B-cell lymphoma in Golden Retrievers reveals a conserved hypermethylome

Epigenetics, 2022
Few recurrent DNA mutations are seen in aggressive canine B cell lymphomas (cBCL), suggesting other frequent drivers. The methylated island recovery assay (MIRA-seq) or methylated CpG-binding domain sequencing (MBD-seq) was used to define the genome-wide
Shirley Chu, Anne Avery, Janna Yoshimoto, Jeffrey N. Bryan   +3 more
doaj   +1 more source

DIFFUSE LARGE B-CELL LYMPHOMA OF THE HEART

Jurnal Kedokteran dan Kesehatan, 2022
Diffuse large B-cell lymphoma (DLBCL) of the heart accounts for only 1% of primary cardiac tumors. Histopathologic examination becomes the primary key for diagnosis and immunohistochemical evaluation for non-Hodgkin lymphoma (NHL) subtype determination ...
Faizah Dwi Tirtasari, Budiarsinta Budiarsinta, Rita Cempaka, Nungki Anggorowati, Nugira Dinantia   +4 more
doaj   +1 more source

Genomic complexity is associated with epigenetic regulator mutations and poor prognosis in diffuse large B-cell lymphoma

OncoImmunology, 2021
Diffuse large B-cell lymphoma (DLBCL) is the most common type of lymphoma with high mutation burdens but a low response rate to immune checkpoint inhibitors.
Hua You, Zijun Y. Xu-Monette, Li Wei, Harry Nunns, Máté L. Nagy, Govind Bhagat, Xiaosheng Fang, Feng Zhu, Carlo Visco, Alexandar Tzankov, Karen Dybkaer, April Chiu, Wayne Tam, Youli Zu, Eric D. Hsi, Fredrick B. Hagemeister, Jooryung Huh, Maurilio Ponzoni, Andrés J.M. Ferreri, Michael B. Møller, Benjamin M. Parsons, J. Han Van Krieken, Miguel A. Piris, Jane N. Winter, Yong Li, Qingyan Au, Bing Xu, Maher Albitar, Ken H. Young   +28 more
doaj   +1 more source

Analyse der Therapie- und Kostenstrukturen bei Patienten mit DLBCL in der GKV

Monitor Versorgungsforschung, 2022
Die vorliegende Analyse zum diffus großzelligen B-Zell-Lymphom (DLBCL) untersucht die Realversorgung von Patienten mit DLBCL anhand einer Auswertung von Abrechnungsdaten der Gesetzliche Krankenversicherung (GKV). Im Rahmen der Analyse wurde festgestellt,
Katja Gehrke, Stefanie Thönnes, Sebastian Lempfert   +2 more
doaj   +1 more source

Diffuse large B-cell lymphoma in a high human immunodeficiency virus (HIV) prevalence, low-resource setting

South African Journal of Oncology, 2020
Background: Diffuse large B-cell lymphoma (DLBCL) is a heterogeneous disease that includes a wide spectrum of lymphomas posing challenges in diagnosis and treatment.
Pumza S. Magangane, Zainab Mohamed, Richard Naidoo   +2 more
doaj   +1 more source

Crossed Cerebellar Diaschisis in Thalamic Lymphoma on 18F-FDG PET/CT

World Journal of Nuclear Medicine, 2022
Primary central nervous system lymphomas (PCNSLs) are extranodal variant forms of non-Hodgkin lymphoma arising within the brain parenchyma, leptomeninges, or spinal cord.
Amit Bhoil, Igor RacuAmoasii, Sobhan Vinjamuri   +2 more
doaj   +1 more source

Construction and Validation of a Novel Nomogram for Predicting the Recurrence of Diffuse Large B Cell Lymphoma Treated with R-CHOP

Pharmacogenomics and Personalized Medicine, 2023
Yuxi Gong,1 Haitao Yan,2 Yefan Yang,1 Boya Zhai,1 Zhendong Huang,1 Zhihong Zhang1 1Department of Pathology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, People’s Republic of China; 2Department of Interventional Radiology, The ...
Gong Y, Yan H, Yang Y, Zhai B, Huang Z, Zhang Z   +5 more
doaj